LNTH Lantheus Holdings, Inc.

NASDAQ
$100.95

Lantheus Holdings, Inc. (LNTH) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is $1.09 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -0.6% since its last earnings release on August 6, 2026.

Lantheus Beat Consensus Estimates
Thursday, August 6, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 7:00 AM ET
Earnings Whisper
-
vs $1.09
Rev est $368.59M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $100.88

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions.

Sector

Healthcare

Industry

Diagnostic Substances

Held By 1 ETFs, by dollar flow